{
  "bio": [
    "Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.",
    "The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.",
    "The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.",
    "In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann."
  ],
  "about": [
    "After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa."
  ]
}